Aaron Lisberg

Articles by Aaron Lisberg

8 Datopotamab Deruxtecan (Dato-DXd) in Advanced Triple- Negative Breast Cancer (TNBC): Updated Results From the Phase 1 TROPION-PanTumor01 Study

ByAditya Bardia, MD, MPH, FASCO,Ian E. Krop,Funda Meric-Bernstam, MD,Anthony W. Tolcher,Toru Mukohara,Aaron Lisberg,Toshio Shimizu,Erika P. Hamilton, MD,Alexander Spira, MD, PhD, FACP,Takahiro Kogawa

April 28th 2023

Latest Updated Articles

Trending on CancerNetwork

Expanding CAR T and Bispecific Antibody Research in HIV-Associated Lymphoma

How Well Does Radiotherapy Pair With Dual PD-1/LAG-3 Blockade in NSCLC?

Ubamatamab Yields Responses in Recurrent Low-Grade Serous Ovarian Cancer

FDA OKs Pirtobrutinib in Frontline CLL/SLL

NDA Submission Begins for Zipalertinib Combo in First-Line EGFR+ NSCLC